Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-18

FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Chengdu Shuode Pharmaceutical Co., Ltd)

View source ↗

Summary

FDA approved a supplemental application for nicardipine hydrochloride by Chengdu Shuode Pharmaceutical Co., Ltd, indicating approval of a supplemental change fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicardipine hydrochloride (Nicardipine)

Snippet

SUPPL AP for NICARDIPINE HYDROCHLORIDE (NICARDIPINE HYDROCHLORIDE)